Artificial Intelligence Diagnostics Market, By Component, By Diagnostics Type, By Region

Description

Artificial Intelligence Diagnostics Market is estimated to be valued at USD 2,207.8 Mn in 2025 and is expected to reach USD 8,481.6 Mn by 2032, growing at a compound annual growth rate (CAGR) of 21.2% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 2,207.8 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	21.20%	2032 Value Projection:	USD 8,481.6 Mn

Artificial intelligence (AI) has powerful potential within healthcare, promising the ability to analyze vast amounts of data quickly and in detail. In a field such as in vitro diagnostics (IVD), which could have transformative implications. Thus, there is an increasing demand for artificial intelligence technology in healthcare sector.

Market Dynamics:

The practice of medical diagnostics is rapidly changing with the development and adoption of Artificial Intelligence (AI). Constant improvements in computer processing have enabled AI-based systems to provide accurate and efficient diagnosis & treatment management plans across various specializations. AI can play a big role in diagnosis and healthcare, with advancements in computing power, learning algorithms, cloud storage, and availability of datasets from electronic health records. It can enable radiologists and pathologists to accurately diagnosis conditions at an early stage to provide adequate & effective treatment.

In a PubMed article on applications of AI in radiology, in December 2017, it was studied that the next breakthrough would not be through an innovative radiology device but through the integration of AI. This integration is likely to take place in stages. AI-based devices are collecting data from imaging technologies, such as ultrasound, MRI, CT, and PET. In its first stage, AI is already performing automatic segmentation of various imaging data and structures to yield significant analytical value and help save the radiologist's time. Over the next decade, AI-based radiology solutions are likely to be used to perform routine tasks such as quantification, segmentation, and pattern recognition prior to the radiologist's analysis, thereby improving patient care delivery.

Key features of the study:

This report provides in-depth analysis of the global artificial intelligence (AI) diagnosis market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global artificial intelligence (AI) diagnosis market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Vuno Inc., CHC Healthcare Group, Aidoc, Imbio, Alivecor Inc., Digital Diagnostics, Retina AI, Canon Medical Systems USA, Healthy Io, Milliman Inc., GE Healthcare, Arterys, Alivecor Inc., Riverain, Lucid Health, Qure.AI, and Cardiologs, among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global artificial intelligence (AI) diagnosis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial intelligence (AI) diagnosis market.

Detailed Segmentation:

Global Artificial Intelligence Diagnostics Market, By Component:
- Software
- Hardware
- Services
Global Artificial Intelligence Diagnostics Market, By Diagnosis Type:
- Cardiology
- Oncology
- Pathology
- Radiology
- Neurology
- Others
Global Artificial Intelligence Diagnostics Market, By Geography:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles:
- Vuno Inc.
- CHC Healthcare Group
- Aidoc
- Imbio
- Alivecor Inc.
- Digital Diagnostics
- Retina AI
- Canon Medical Systems USA
- Healthy IO
- Milliman Inc.
- GE Healthcare
- Arterys
- Alivecor Inc.
- Riverain
- Lucid Health
- Qure.AI
- Cardiologs

Product Code: CMI6123

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Component
- Market Snapshot, By Service Type
- Market Snapshot, By Geography
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Rising incidence of infectious diseases
- Concerns about the use of thermometers
- High demand for Artificial Intelligence (AI) diagnostics devices
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Artificial Intelligence (AI) Diagnostics Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Artificial Intelligence (AI) Diagnostics Market, By Component, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Hardware
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Artificial Intelligence (AI) Diagnostics Market, By Diagnostics Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Pathology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Radiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global Artificial Intelligence (AI) Diagnostics Market, By Geography, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Type, 2020-2032,(US$ Mn)
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Type, 2020-2032,(US$ Mn)
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Type, 2020-2032,(US$ Mn)
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Type, 2020-2032,(US$ Mn)
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Type, 2020-2032,(US$ Mn)
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Type, 2020-2032,(US$ Mn)

8. Competitive Landscape

Vuno Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
CHC Healthcare Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Aidoc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Imbio
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Alivecor Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Digital Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Retina AI
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Canon Medical Systems USA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Healthy IO
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Milliman Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GE Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Arterys
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Alivecor Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Riverain
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Lucid Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Qure.AI
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cardiologs
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views

9. Section

Research Methodology
About us